from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1359/-

LFCtreatmentdescriptionclass of inhibitor

-0.304

Amikacinug/mL Amikacintranslation

0.969

Cap5-10ug/mL Capreomycintranslation

-1.078

Rox10-50 ug/mL Roxithromycintranslation

-0.392

SM2-5 ug/mL Streptomycintranslation

-0.319

Tet5-10 ug/mL Tetracyclinetranslation

1.029

Rif0.2-5ug/mL Rifampicintranscription

0.502

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.975

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.069

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.423

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.640

Clofazimine10-13 ug/mL Clofaziminerespiration

0.736

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.315

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.312

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.370

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.304

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.843

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.350

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.027

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.322

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.845

KCN5-20 ug/mL Potassium cyaniderespiration

0.014

NaN30.2-2 mM Sodium aziderespiration

-0.235

Nigericin50 uM Nigericinrespiration

0.415

TRC10-150 ug/mL Triclosanrespiration

0.078

TRZ10-25 ug/mL Thioridazinerespiration

-0.878

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.248

menadione6-10 ug/mL Menadionerespiration

0.673

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.527

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.343

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.465

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.657

NRP_1Non-replicating persistence stage 1dosRassociated

-0.364

Amp0.2mg/mL AmpicillincellWall

0.111

Cephalexin20-100 ug/mL CephalexincellWall

0.534

Cerulenin0.32-5 ug/mL CerulenincellWall

0.453

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.128

EMB10-20 ug/mL EthambutolcellWall

-0.797

Eta12-40 ug/mL EthionamidecellWall

-1.119

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.320

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.009

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.327

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.234

BZA0.12 mg/mL BenzamidearomaticAmides

-0.195

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.763

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.478

H2O24 mM hydrogen peroxideDNAdamaging

0.188

Levo10 ug/mL LevofloxacinDNAdamaging

-0.351

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.318

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.348

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.137

UVUV-irradiationDNAdamaging

0.144

ARP41-4 ug/mL Antitubercular compound ARP4?

0.288

Antimycin12.5-50 ug/mL Antimycin A?

0.250

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.725

PA_110-50 ug/mL Antitubercular compound PA-1?

1.166

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.460

PA8240.2-2 ug/mL PA-824?

-0.073

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.499

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.652

Verapamil50 uM Verapamil?

1.142

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.524

methoxatin10-20 ug/mL Methoxatin?